Control of Taenia solium Cysticercosis/Taeniosis

Advances in Parasitology

Volumn 61, Issue , 2006, Pages 509-566

  Willingham III, Arve Lee ^a   Engels, Dirk ^b  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBENDAZOLE; ALBENDAZOLE SULFOXIDE; ANTICONVULSIVE AGENT; ANTIPARASITIC AGENT; BENZIMIDAZOLE; DEXAMETHASONE; NICLOSAMIDE; OXFENDAZOLE; PRAZIQUANTEL; PREDNISONE; STEROID;

ANOREXIA; ANTIBODY DETECTION; ANTIGEN DETECTION; COMPUTER ASSISTED TOMOGRAPHY; CYSTICERCOSIS; DISEASE CONTROL; DNA DETERMINATION; DRUG SAFETY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPILEPSY; FECES ANALYSIS; GEOGRAPHIC DISTRIBUTION; HEADACHE; HUMAN; LETHARGY; NEUROCYSTICERCOSIS; NEUROLOGIC DISEASE; NONHUMAN; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; SEIZURE; SERODIAGNOSIS; SKIN BIOPSY; SUBCUTANEOUS NODULE; SWINE; TAENIA SOLIUM; TAENIASIS; VACCINATION; WORLD HEALTH ORGANIZATION;

ANIMALS; ANTHELMINTICS; CYSTICERCOSIS; HEALTH PLANNING GUIDELINES; HUMANS; POPULATION SURVEILLANCE; SWINE; SWINE DISEASES; TAENIA SOLIUM; TAENIASIS; VACCINATION;

TAENIA SOLIUM;

EID: 33646933487     PISSN: 0065308X     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S0065-308X(05)61012-3     Document Type: Review

References (231)

1. Acevedo-Hernandez A. Economic impact of porcine cysticercosis. In: Flisser A., Willms K., Lacletter J.P., Larralde C., Ridaura C., and Beltran F. (Eds). Cysticercosis: Present State of Knowledge and Perspectives (1982), Academic Press, New York 63
2. Allan J.C., Avila G., Garcia-Noval J., Flisser A., and Craig P.S. Immunodiagnosis of taeniasis by coproantigen detection. Parasitology 101 (1990) 473-477
3. Allan J.C., Mencos F., Garcia-Noval J., Sarti E., and Flisser A. Dipstick dot ELISA for detection of Taenia coproantigens in humans. Parasitology 107 (1993) 79-85
4. Allan, J. C., Velasquez-Tohom, M., Fletes, C., Torres-Alvarez, R., Lopez-Virula, G., Yurrita, P., Soto de Alfaro, H., Rivera, A. and Garcia-Noval, J. (1997). Mass chemotherapy for intestinal Taenia solium infection: effect on prevalence in humans and pigs. Transactions of the Royal Society of Tropical Medicine and Hygiene, 91, 595-598.
5. Allan J.C., Velasquez-Tohom M., Garcia-Noval J., Torres-Alvarez R., Yurrita P., Fletes C., de Mata F., Soto de Alfaro H., and Craig P.S. Epidemiology of intestinal taeniasis in four rural Guatemalan communities. Annals of Tropical Medicine and Parasitology 90 (1996) 157-165
6. Al Shahrani D., Frayha H.H., Dabbagh O., and Al Shail E. First case of neurocysticercosis in Saudi Arabia. Journal of Tropical Pediatrics 49 (2003) 58-60
7. Avodé D.G., Capo-Chichi O.B., Gandaho P., Bouteille B., and Dumas M. Epilepsie provoquée par la cysticercose. A propos d'une enquête sociologique et culturelle réalisée à Savalou au Bénin. Bulletin de la Societe de Pathologie Exotique 89 (1996) 45-47
8. Bern C., Garcia H.H., Evans C., Gonzalez A.E., Verastegui M., Tsang V.C.W., and Gilman R.H. Magnitude of the disease burden from neurocysticercosis in a developing country. Clinical Infectious Diseases 29 (1999) 1203-1209
9. Blanton R.E., Wachira T.M., Zeyhle E.E., Njoroge E.M., Magambo J.K., and Schantz P.M. Oxfendazole treatment for cystic hydatid disease in naturally infected animals. Antimicrobial Agents and Chemotherapy 42 (1998) 601-605
10. Boa M.E., Kassuku A.A., Willingham A.L., Keyyu J.D., Phiri I.K., and Nansen P. Intensity, distribution and density of Cysticercus cellulosae by muscle groups and organs in naturally infected local slaughter pigs in Mbulu district of Tanzania. Veterinary Parasitology 106 (2002) 155-164
11. Botero D., and Castano S. Treatment of cysticercosis with praziquantel in Colombia. American Journal of Tropical Medicine and Hygiene 31 (1982) 811-821
12. Brand J.A., and Tsang V.C. A rapid immunoblot assay (Western blot) to detect specific antibodies for human immunodeficiency virus, Schistosoma mansoni, and Taenia solium (cysticercosis). Journal of Immunoassay 10 (1989) 237-255
13. Brandt J.R., Geerts S., De Deken R., Kumar V., Ceulemans F., Brijs L., and Falla N. A monoclonal antibody-based ELISA for the detection of circulating excretory-secretory antigens in Taenia saginata cysticercosis. International Journal for Parasitology 22 (1992) 471-477
14. Buback J.L., Schulz K.S., Walker M.A., and Snowden K.F. Magnetic resonance imaging of the brain for diagnosis of neurocysticercosis in a dog. Journal of the American Veterinary Medical Association 208 (1996) 1846-1848
15. Bucardo F., Meza-Lucas A., Espinoza F., Garcia-Jeronimo R.C., Garcia-Rodea R., and Correa D. The seroprevalence of Taenia solium cysticercosis among epileptic patients in Leon, Nicaragua, as evaluated by ELISA and western blotting. Annals of Tropical Medicine and Parasitology 99 (2005) 41-45
16. Campbell G.D., and Farrell V.J. Brain scans, epilepsy and cerebral cysticercosis. South African Medical Journal 72 (1987) 885-886
17. Carabin H., Budke C.M., Cowan L.D., Willingham III A.L., and Torgerson P.R. Methods for assessing the burden of parasitic zoonoses: echinococcosis and cysticercosis. Trends in Parasitology 21 (2005) 327-333
18. Carabin, H., Krecek, R.C., Cowan, L.D., Michael, L., Foyaca-Sibat, H., Nash, T. and Willingham, A.L. (2006). Estimation of the monetary burden of Taenia solium cysticercosis in Eastern Cape Province, South Africa. Tropical Medicine and International Health (in press).
19. Carpio A. Neurocysticercosis: an update. Lancet Infectious Diseases 2 (2002) 751-762
20. Carpio A., Escobar A., and Hauser W.A. Cysticercosis and epilepsy: a critical review. Epilepsia 39 (1998) 1025-1040
21. Carpio A., and Hauser W.A. Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis. Neurology 59 (2002) 1730-1734
22. Carpio A., Santillan F., Leon P., Flores C., and Hauser W.A. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?. Archives of Internal Medicine 155 (1995) 1982-1988
23. Carrique-Mas J., Iihoshi N., Widdowson M.A., Roca Y., Morales G., Quiroga J., Cejas F., Caihuara M., Ibarra R., and Edelsten M. An epidemiological study of Taenia solium cysticercosis in a rural population in the Bolivian Chaco. Acta Tropica 80 (2001) 229-235
24. Chang K.H., Kim W.S., Cho S.Y., Han M.C., and Kim C.W. Comparative evaluation of brain CT and ELISA in the diagnosis of neurocysticercosis. American Journal of Neuroradiology 9 (1988) 125-130
25. Choromanski L., Estrada J.J., and Kuhn R.E. Detection of antigens of larval Taenia solium in the cerebrospinal fluid of patients with the use of HPLC and ELISA. Journal of Parasitology 76 (1990) 69-73
26. Colley D. Parasitic diseases: opportunities and challenges in the 21st century. Memorias de Instituto Oswaldo Cruz 95 supplement 1 (2000) 79-87
27. Corona T., Lugo R., Medina R., and Sotelo J. Single-day praziquantel therapy for neurocysticercosis. New England Journal of Medicine 334 (1996) 125
28. Correa D., Sandoval M.A., Harrison L.J., Parkhouse R.M., Plancarte A., Meza-Lucas A., and Flisser A. Human neurocysticercosis: comparison of enzyme immunoassay capture techniques based on monoclonal and polyclonal antibodies for the detection of parasite products in cerebrospinal fluid. Transactions of the Royal Society of Tropical Medicine and Hygiene 83 (1989) 814-816
29. Cruz I., Cruz M.E., Teran W., Schantz P.M., Tsang V., and Barry M. Human subcutaneous Taenia solium cysticercosis in an Andean population with neurocysticercosis. American Journal of Tropical Medicine and Hygiene 51 (1994) 405-407
30. Cruz M., Davis A., Dixon H., Pawlowski Z.S., and Porano J. Operational studies on the control of Taenia solium taeniasis/cysticercosis in Ecuador. Bulletin of World Health Organization 67 (1989) 401-407
31. Cruz M.E., Cruz I., Preux P.M., Schantz P., and Dumas M. Headache and cysticercosis in Ecuador, South America. Headache 35 (1995) 93-97
32. Cruz M.E., Schantz P.M., Cruz I., Espinosa P., Preux P.M., Cruz A., Benitez W., Tsang V.C.W., Fermoso J., and Dumas M. Epilepsy and neurocysticercosis in an Andean community. International Journal of Epidemiology 28 (1999) 799-803
33. Cysticercosis Working Group in Peru (CWGP). The marketing of cysticercotic pigs in the sierra of Peru. Bulletin of the World Health Organization 71 (1993) 223-228
34. de Aluja A.S., Marinez J.J., and Villalobos A. Taenia solium cysticercosis in young pigs: age at first infection and histological characteristics. Veterinary Parastiology 76 (1998) 71-79
35. de Aluja A.S., Villalobos N.M., Nava G., Toledo A., Martínez J.J., Plancarte A., Rodarte L.F., Fragoso G., and Sciutto E. Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs. Vaccine 23 (2005) 4062-4069
36. DeGiorgio C., Pietsch-Escueta S., Tsang V., Corral-Leyva G., Ng L., Medina M.T., Astudillo S., Padilla N., Leyva P., Martinez L., Noh J., Levine M., del Villasenor R., and Sorvillo F. Sero-prevalence of Taenia solium cysticercosis and Taenia solium taeniasis in California, USA. Acta Neurologica Scandinavica 111 (2005) 84-88
37. de Kaminsky R.G. Albendazole treatment in human taeniasis. Transactions of the Royal Society of Tropical Medicine and Hygiene 85 (1991) 648-650
38. Del Brutto O.H. Prognostic factors for seizure recurrence after withdrawal of antiepileptic drugs in patients with neurocysticercosis. Neurology 44 (1994) 1706-1709
39. Del Brutto O.H., Rajshekar V., White Jr. A.C., Tsang V.C., Nash T.E., Takayanagui O.M., Schantz P.M., Evans C.A., Flisser A., Correa D., Botero D., Allan J.C., Sarti E., Gonzalez A.E., Gilman R.H., and Garcia H.H. Proposed diagnostic criteria for neurocysticercosis. Neurology 57 (2001) 177-183
40. Del Brutto O.H., Santibáñez R., Hidrovo L., Rodríguez S., Dìaz-Calderón E., Navas C., Gilman R.H., Cuesta F., Mosquera A., Gonzalez A.E., Tsang V.C.W., and Garcia H.H. Epilepsy and neurocysticercosis in Atahualpa: a door-to-door survey in rural coastal Ecuador. Epilepsia 46 (2005) 583-587
41. Del Brutto O.H., Wadia N.H., Dumas M., Cruz M., Tsang V.C., and Schantz P.M. Proposal of diagnostic criteria for human cysticercosis and neurocysticercosis. Journal of Neurolological Sciences 142 (1996) 1-6
42. Delgado C.L. Rising consumption of meat and milk in developing countries has created a food revolution. Journal of Nutrition 133 11 supplement 2 (2003) 3907S-3910S
43. De N.V., Chau L.V., and Dat D.T. Infection of intestinal helminths in several places along the Srepok and Krongana rivers in Dak Lak Province. Journal of Malaria and Parasite Diseases Control 2 (1998) 42-43
44. Diop A.G., de Boer H.M., Mandlhate C., Prilipko L., and Meinardi H. The global campaign against epilepsy in Africa. Acta Tropica 87 (2003) 149-159
45. Dorny, P., Brandt, J. and Geerts, S. (2005). Detection and diagnosis, In: WHO/FAO/OIE Guidelines for the Surveillance, Prevention and Control of Taeniosis/Cysticercosis (K.D. Murrell, ed.), pp. 45-52. Paris: Office International des Epizooties.
46. Dorny P., Brandt J., Zoli A., and Geerts S. Immunodiagnostic tools for human and porcine cysticercosis. Acta Tropica 87 (2003) 79-86
47. Dorny P., Phiri I.K., Vercruysse J., Gabriel S., Willingham III A.L., Brandt J., Victor B., Speybroeck N., and Berkvens D. A Bayesian approach for estimating values for prevalence and diagnostic test characteristics of porcine cysticercosis. International Journal for Parasitology 34 (2004) 569-576
48. Dueger E.L., Moro P.L., and Gilman R.H. Oxfendazole treatment of sheep with naturally acquired hydatid disease. Antimicrobial Agents and Chemotherapy 43 (1999) 2263-2267
49. Ehnert K.L., Roberto R.R., Barrett L., Sorvillo F.J., and Rutherford III G.W. Cysticercosis: first 12 months of reporting in California. Bulletin of the Pan American Health Organization 26 (1992) 165-172
50. Engels D., Urbani C., Belotto A., Meslin F., and Savioli L. The control of human (neuro)cysticercosis: which way forward?. Acta Tropica 87 (2003) 177-182
51. Erhart A., Dorny P., De N.V., Vien H.V., Thach D.C., Toan N.D., Cong L.D., Geerts S., Speybroeck N., Berkvens D., and Brandt J. Taenia solium cysticercosis in a village in northern Vietnam: seroprevalence study using an ELISA for detecting circulating antigen. Transactions of the Royal Society of Tropical Medicine and Hygiene 96 (2002) 270-272
52. Escobedo F., Penagos P., Rodriguez J., and Sotelo J. Albendazole therapy for neurocysticercosis. Archives of Internal Medicine 147 (1987) 738-741
53. Fleury A., Bouteille B., Garcia E., Marquez C., Preux P.M., Escobedo F., Sotelo J., and Dumas M. Neurocysticercosis: validity of ELISA after storage of whole blood and cerebrospinal fluid on paper. Tropical Medicine and International Health 6 (2001) 688-693
54. Fleury A., Gomez T., Alvarez I., Meza D., Huerta M., Chavarria A., Carrillo-Mezo R.A., Lloyd C., Dessein A., Preux P.M., Dumas M., Larralde C., Sciutto E., and Fragoso G. High prevalence of calcified silent neurocysticercosis in a rural village of Mexico. Neuroepidemiology 22 (2003) 139-145
55. Flisser A. Neurocysticercosis in Mexico. Parasitology Today 4 (1988) 131-137
56. Flisser A. Taeniasis and cysticercosis due to Taenia solium. In: Sun T. (Ed). Progress in Clinical Parasitology (1994), CRC Press, New York 77-116
57. Flisser A., Gonzalez D., Shkurovich M., Madrazo I., Correa D., Rodríguez-Carbajal J., Cohen S., Rodríguez del Rosal E., Collado M., Fernandez B., Fernandez F., and Aluja A.S. Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. I. Radiological, physiological and histopathological studies. Parasitology Research 76 (1990) 263-269
58. Flisser A., Guaci C.G., Zoli A., Martinez-Ocaña J., Garza-Rodriguez A., Domínguez-Alpizar J.L., Maravilla P., Rodríguez-Canul R., Avila G., Aguilar-Vegas L., Kyngdon C., Geerts S., and Lightowlers M.W. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens. Infection and Immunity 72 (2004) 5292-5297
59. Flisser A., Madrazo I., Plancarte A., Schantz P., Allan J., Craig P., and Sarti E. Neurological symptoms in occult neurocysticercosis alter single taeniacidal dose of praziquantel. Lancet 342 (1993) 748
60. Flisser A., Sarti E., Lightowlers M., and Schantz P. Neurocysticercosis: regional status, epidemiology, impact and control measures in the Americas. Acta Tropica 87 (2003) 43-51
61. Flisser A., Vázquez-Mendoza A., Martiñez-Ocaña J., Gómez-Colín E., Sánchez-Leyva R., and Medina-Santillán R. Short report: evaluation of a self-detection tool for tapeworm carriers for use in public health. American Journal of Tropical Medicine and Health 72 (2005) 510-512
62. Gaffo A.L., Guillen-Pinto D., Campos-Olazabal P., and Burneo J.G. Cysticercosis as the main cause of partial seizures in children in Peru. Revista de Neurologia 39 (2004) 924-926 (Spanish)
63. Garcia, H.H. (2002). Effectiveness of an interventional control program for human and porcine Taenia solium cysticercosis in field conditions, p. 227. Thesis, Baltimore, Maryland: Johns Hopkins University.
64. Garcia H.H., and del Brutto O.H. Heavy nonencephalitic cerebral cysticercosis in tapeworm carriers. Neurology 53 (1999) 1582-1584
65. Garcia H.H., Del Brutto O.H., Nash T.E., White Jr. A.C., Tsang V.C.W., and Gilman R.H. New concepts in the diagnosis and management of neurocysticercosis (Taenia solium). American Journal of Tropical Medicine and Hygiene 72 (2005) 3-9
66. Garcia H.H., Evans C.A.W., Nash T.E., Takayanagui O.M., White Jr. A.C., Botero D., Rajshekhar V., Tsang V.C.W., Schantz P.M., Allan J.C., Flisser A., Correa D., Sarti E., Friedland J.S., Martinez S.M., Gonzalez A.E., Gilman R.H., and del Brutto O.H. Current consensus guidelines for treatment of neurocysticercosis. Clinical Microbiology Reviews 15 (2002) 747-756
67. Garcia H.H., Gilman R.H., Catacora M., Verastegui M., Gonzalez A.E., and Tsang V.C. Serologic evolution of neurocysticercosis patients after antiparasitic therapy. Journal of Infectious Diseases 175 (1997) 486-489
68. Garcia H.H., Gilman R.H., Gonzalez A.E., Pacheco R., Verastegui M., and Tsang V.C. Human and Porcine Taenia solium infection in a village in the highlands of Cusco, Peru. Acta Tropica 73 (1999) 31-36
69. Garcia H.H., Gilman R.H., Tovar M.A., Flores E., Jo R., Tsang V.C., Diaz F., Torres P., and Miranda E. Factors associated with Taenia solium cysticercosis analysis of nine hundred forty-six Peruvian neurologic patients. American Journal of Tropical Medicine and Hygiene 52 (1995) 145-148
70. Garcia H.H., Gonzalez A.E., Evans C.A.W., and Gilman R.H. Taenia solium cysticercosis. Lancet 362 (2003) 547-556
71. Garcia H.H., Gonzalez A.E., Gilman R.H., Bernal T., Rodríguez S., Pretell E.J., Azcurra O., Parkhouse R.M., Tsang V.C., Harrison L.J., and the Cysticercosis Working Group in Peru. Circulating parasite antigen in patients with hydrocephalus secondary to neurocysticercosis. American Journal of Tropical Medicine and Hygiene 66 (2002) 427-430
72. Garcia H.H., Gonzalez A.E., Gilman R.H., Palacios L.G., Jiménez I., Rodríguez S., Verastegui M., Wilkins P., Tsang V.C.W., and the Cysticercosis Working Group in Peru. Transient antibody response in Taenia solium infection in field conditions, a major contributor to high seroprevalence. American Journal of Tropical Medicine and Hygiene 65 (2001) 31-34
73. Garcia H.H., Harrison L.J.S., Parkhouse R.M.E., Montenegro T., Martinez S.M., Tsang V.C.W., and Gilman R.H. A specific antigen-detection ELISA for the diagnosis of human neurocysticercosis. Transactions of the Royal Society of Tropical Medicine and Hygiene 92 (1998) 411-414
74. Garcia H.H., Parkhouse R.M.E., Gilman R.H., Montenegro T., Bernal T., Martinez S.M., Gonzalez A.E., Tsang V.C.W., Harrison L.J.S., and the Cysticercosis Working Group in Peru. Serum antigen detection in the diagnosis, treatment and follow-up of neurocysticercosis patients. Transactions of the Royal Society of Tropical Medicine and Hygiene 94 (2000) 673-676
75. Garcia H.H., Pretell E.J., Gilman R.H., Martinez S.M., Moulton L.H., Del Brutto O.H., Genaro Herrera M.D., Evans C.A.W., and Gonazalez A.E. A trial of antiparasitic treatment to reduce the rate of seizures due to cerebral cysticercosis. New England Journal of Medicine 350 (2004) 249-258
76. Garcia-Noval J., Allan J.C., Fletes C., Moreno E., DeMata F., Torres-Alvarez R., Soto de Alfaro H., Yurrita P., Higueros-Morales H., Mencos F., and Craig P.S. Epidemiology of Taenia solium taeniasis and cysticercosis in two rural Guatemalan communities. American Journal of Tropical Medicine and Hygiene 55 (1996) 282-289
77. Gauci C.G.P., Flisser A., and Lightowlers M.W. A Taenia solium oncosphere protein homologous to host-protective Taenia ovis and Taenia saginata 18 kDa antigens. International Journal for Parasitology 28 (1998) 757-760
78. Gauci C.G.P., and Lightowlers M. Alternative splicing and sequence diversity of transcripts from the oncosphere stage of Taenia solium with homology to the 45W antigen of Taenia ovis. Molecular Biochemistry and Parasitolgy 112 (2001) 173-181
79. Gemmell M., Matyas Z., Pawlowski Z., Soulsby E.J.L., Larralde C., Nelson G.S., and Rosicky B. Guidelines for Surveillance, Prevention and Control of Taeniasis/Cysticercosis (VPH/83.49) (1983), WHO, Geneva
80. Gilman R.H., Del Brutto O.H., Garcia H.H., and Martinez M. Prevalence of taeniosis among patients with neurocysticercosis is related to severity of infection. Neurology 55 (2000) 1062
81. Gonzalez A.E. Control of Taenia solium with porcine chemotherapy. In: Singh G., and Prabhakar S. (Eds). Taenia solium Cysticercosis. From Basic to Clinical Science (2002), CABI Publishing, Wallingford, United Kingdom 431-435
82. Gonzalez A.E., Cama V., Gilman R.H., Tsang V.C., Pilcher J.B., Chavera A., Castro M., Montenegro T., Verastegui M., Miranda E., and Bazalar H. Prevalence and comparison of serologic assays, necropsy, and tongue examination for the diagnosis of porcine cysticercosis in Peru. American Journal of Tropical Medicine and Hygiene 43 (1990) 194-199
83. Gonzalez A.E., Falcon N., Gavidia C., Garcia H.H., Tsang V.C., Bernal T., Romero M., and Gilman R.H. Treatment of porcine cysticercosis with oxfendazole: a dose-response trial. Veterinary Record 141 (1997) 420-422
84. Gonzalez A.E., Falcon N., Gavidia C., Garcia H.H., Tsang V.C., Bernal T., Romero M., and Gilman R.H. Time-response curve of oxfendazole in the treatment of swine cysticercosis. American Journal of Tropical Medicine and Hygiene 59 (1998) 832-836
85. Gonzalez A.E., Garcia H.H., Gilman R.H., Gavidia C.M., Tsang V.C., Bernal T., Falcon N., Romero M., and Lopez-Urbina M.T. Effective, single-dose treatment of porcine cysticercosis with oxfendazole. American Journal of Tropical Medicine and Hygiene 54 (1996) 391-394
86. Gonzalez A.E., Garcia H.H., Gilman R.H., Lopez M.T., Gavidia C., McDonald J., Pilcher J.B., and Tsang V.C. Treatment of porcine cysticercosis with albendazole. American Journal of Tropical Medicine and Hygiene 53 (1995) 571-574
87. Gonzalez A.E., Garcia H.H., Gilman R.H., and Tsang V.C. Control of Taenia solium. Acta Tropica 87 (2003) 103-109
88. Gonzalez A.E., Gauci C.G., Barber D., Gilman R.H., Tsang V.C.W., Garcia H.H., Verastegui M., and Lightowlers M.W. Short report: vaccination of pigs to control human neurocysticercosis. American Journal of Tropical Medicine and Hygiene 72 (2005) 837-839
89. Gonzalez, A.E., Gavidia, C., Falcon, N., Bernal, T., Verastegui, M., Garcia, H.H., Gilman, R.H., Tsang, V.C. and Cisticercosis Working Group in Peru (2001). Protection of pigs with cysticercosis from further infections after treatment with oxfendazole. American Journal of Tropical Medicine and Hygiene 65, 15-18.
90. Gonzalez L.M., Montero E., Harrison L.J.S., Parkhouse R.M.E., and Gárate T. Differential diagnosis of Taenia saginata and Taenia solium infection by PCR. Journal of Clinical Microbiology 38 (2000) 737-744
91. Gonzalez L.M., Montero E., Sciutto E., Harrison L.J., Parkhouse R.M., and Garate T. Differential diagnosis of Taenia saginata and Taenia solium infections: from DNA probes to polymerase chain reaction. Transactions of the Royal Society of Tropical Medicine and Hygiene 96 supplement 1 (2002) S243-S250
92. Gonzalez A.E., Verastegui M., Noh J.C., Gaviria C., Falcon N., Bernal T., Garcia H.H., Tsang V.C.W., Gilman R.H., Wilkins P.P., and the Cysticercosis Working Group in Peru. Persistence of passively transferred antibodies in porcine Taenia solium cysticercosis. Veterinary Parasitology 86 (1999) 113-118
93. Goodman K.A., Ballagh S.A., and Carpio A. Case-control study of seropositivity for cysticercosis in Cuenca, Ecuador. American Journal of Tropical Medicine and Hygiene 60 (1999) 70-74
94. Griffiths R.I., Schrammel P.N., Morris G.L., Wills S.H., Labiner D.M., and Strauss M.J. Payer costs of patients diagnosed with epilepsy. Epilepsia 40 (1999) 351-358
95. Grill J., Rakotomalala W., Andriantsimahavandy A., Boisier P., Guyon P., Roux J., and Esterre P. High prevalence of serological markers of cysticercosis among epileptic Malagasy children. Annals of Tropical Paediatrics 16 (1996) 185-191
96. In: Haddix A.C., Teutsch S., and Corso P. (Eds). Prevention Effectiveness. A Guide to Decision Analysis and Economic Evaluation (2003), Oxford University Press, Oxford, UK
97. Hall A., Latham M.C., Crompton D.W.T., and Stephenson L.S. Taenia saginata (Cestoda) in western Kenya: the reliability of faecal examinations in diagnosis. Parasitology 83 (1981) 91-101
98. Hancock K., Khan A., Williams F.B., Yushak M.L., Pattabhi S., Noh J., and Tsang V.C.W. Characterization of the 8-kilodalton antigens of Taenia solium metacestodes and evaluation of their use in an enzyme-linked immunosorbent assay for serodiagnosis. Journal of Clinical Microbiology 41 (2003) 2577-2586
99. Hancock K., Pattabhi S., Greene R.M., Yushak M.L., Williams F., Khan A., Priest J.W., Levine M.Z., and Tsang V.C.W. Characterization and cloning of GP50, a Taenia solium antigen diagnostic for cysticercosis. Molecular & Biochemical Parasitology 133 (2004) 115-124
100. Hira P.R., Francis I., Abdella N.A., Gupta R., Ai-Ali F.M., Grover S., Khalid N., Abdeen S., Iqbal J., Wilson M., and Tsang V.C. Cysticercosis: imported and autochthonous infections in Kuwait. Transactions of the Royal Society of Tropical Medicine and Hygiene 98 (2004) 233-239
101. Huerta M., de Aluja A.S., Fragoso G., Toledo A., Villalobos N., Hernández M., Gevorkian G., Acero G., Díaz A., Alvarez I., Avila R., Beltrán C., Garcia G., Martinez J.J., Sarralde C., and Sciutto E. Synthetic peptide vaccine against Taenia solium pig cysticercosis: successful vaccination in a controlled field trial in rural Mexico. Vaccine 20 (2002) 262-266
102. Huerta M., Sciutto E., Garcia G., Villalobos N., Hernández M., Fragoso G., Díaz J., Díaz A., Ramírez R., Luna S., Garcia J., Aguilar E., Espinoza S., Castilla G., Bobadilla J.R., Avila R., José M.V., Larralde C., and de Aluja A.S. Vaccination against Taenia solium cysticercosis in underfed rustic pigs of México: roles of age, genetic background and antibody response. Veterinary Parasitology 90 (2000) 209-219
103. International Task Force for Disease Eradication (ITFDE) (1993). Recommendations of the International Task Force for Disease Eradication. Morbidity and Mortality Weekly Report 42, RR-16, 1-46.
104. International Task Force for Disease Eradication II (ITFDE II) (2003). Summary of the Fourth Meeting of the ITFDE (II), April 16, 2003. http://www.cartercenter.org/documents/1367.pdf
105. Ito A., and Craig P.S. Immunodiagnosis and molecular approaches for the detection of taeniid cestode infections. Trends in Parasitology 19 (2003) 377-381
106. Ito A., Nakao M., and Wandra T. Human taeniasis and cysticercosis in Asia. Lancet 362 (2003) 1918-1920
107. Ito A., Plancarte A., Ma L., Kong Y., Flisser A., Cho S.Y., Liu Y.H., Kamhawi S., Lightowlers M., and Schantz P.M. Novel antigens for neurocysticercosis: simple method for preparation and evaluation for serodiagnosis. American Journal of Tropical Medicine and Hygiene 59 (1998) 291-294
108. Ito A., Plancarte A., Nakao M., Nakaya K., Ikejima T., Piao Z.X., Kanazawa T., and Margono S.S. ELISA and immunoblot using purified glycoproteins for serodiagnosis of cysticercosis in pigs naturally infected with Taenia solium. Journal of Helminthology 73 (1999) 363-365
109. Ito A., Putra M.I., Subahar R., Sato M.O., Okamoto M., Sako Y., Nakao M., Yamasaki H., Nakaya K., Craig P.S., and Margono S.S. Dogs as alternative intermediate hosts of Taenia solium in Papua (Irian Jaya), Indonesia confirmed by highly specific ELISA and immunoblot using native and recombinant antigens and mitochondrial DNA analysis. Journal of Helminthology 76 (2002) 311-314
110. Ito A., Sako Y., Nakao M., and Nakaya K. Neurocysticercosis in Asia: serology/seroepidemiology in humans and pigs. In: Craig P., and Pawlowski Z. (Eds). Cestode Zoonoses: Echinococcosis and Cysticercosis (2002), IOS Press, Amsterdam 25-31
111. Ito A., Urbani C., Qui J.M., Vuitton D.A., Qui D.C., Heath D.D., Craig P.S., Zheng F., and Schantz P.M. Control of echinococcosis and cysticercosis; a public health challenge to international cooperation in China. Acta Tropica 86 (2003) 3-17
112. Ito A., Wandra T., Yamasaki H., Nakao M., Sako Y., Nakaya K., Margono S.S., Suroso T., Gauci C., and Lightowlers M.W. Cysticercosis/taeniasis in Asia and the Pacific. Vector-Borne and Zoonotic Diseases 4 (2004) 95-107
113. Jafri H.S., Torrico F., Noh J.C., Bryan R.T., Balderrama F., Pilcher J.B., and Tsang V.C. Application of the enzyme linked immunoelectrotransfer blot to paper blood spots to estimate seroprevalence of cysticercosis in Bolivia. American Journal of Tropical Medicine and Hygiene 58 (1998) 313-315
114. Jauregui P.H., and Marquez-Monter H. Cysticercosis of the brain in dogs in Mexico City. American Journal of Veterinary Research 38 (1977) 1641-1642
115. Jeri C., Gilman R.H., Lescano A.G., Mayta H., Ramirez M.E., Gonzalez A.E., Nazerali R., and Garcia H.H. Species identification after treatment for human taeniasis. The Lancet 363 (2004) 949-950
116. Joshi D.D., Maharjan M., Johansen M.V., Willingham III A.L., and Sharma M. Improving meat inspection and control in resource-poor communities: the Nepal example. Acta Tropica 87 (2003) 119-127
117. Jung H., Hurtado M., Sanchez M., Medina M.T., and Sotelo J. Plasma and cerebrospinal fluid levels of albendazole and praziquantel in patients with neurocysticercosis. Neuropharmacology 13 (1990) 559-564
118. Kaur M., Joshi K., Ganguly N.K., Mahajan R.C., and Malla N. Evaluation of the efficacy of albendazole against the larvae of Taenia solium in experimentally infected pigs, and kinetics of the immune response. International Journal of Parasitology 25 (1995) 1443-1450
119. Keilbach N.M., de Aluja A.S., and Sarti-Gutierrez E. A programme to control taeniasis-cysticercosis (T. solium): experiences in a Mexican village. Acta Leidensia 57 (1989) 181-189
120. Kriel, J.D. (1997). Taenia solium in African materiae medicae: fact or fantasy. Report of an International Workshop on Cysticercosis. Agricultural Research Council, Onderstepoort Veterinary Institute, South Africa, 18-19 August 1997.
121. Kriel J.D., and Joubert J.J. African concepts of helminth infections: an anthropological perspective. Journal of the South African Veterinary Association 67 (1996) 175
122. Krishnan A., Sahariah S.U., and Kapoor S.K. Cost of epilepsy in patients attending a secondary-level hospital in India. Epilepsia 45 (2004) 289-291
123. Lam K.T., and Tan N.T. Some comments on taeniasis and cysticercosis in several northern provinces of Vietnam. Journal of Malaria and Parasitic Diseases Control 4 (1992) 39-44
124. Lekule F.P., and Kyvsgaard N.C. Improving pig husbandry in tropical resource-poor communities and its potential to reduce risk of porcine cysticercosis. Acta Tropica 87 (2003) 111-117
125. Leutsher P., and Andriantsimahavandy A. Cysticercosis in Peace Corps Volunteers in Madagascar. New England Journal of Medicine 350 (2004) 311-312
126. Lightowlers M. Vaccines for prevention of cysticercosis. Acta Tropica 87 (2003) 129-135
127. Lightowlers M.W. Eradication of Taenia solium cysticercosis: a role for vaccination of pigs. International Journal of Parasitology 29 (1999) 811-817
128. Lightowlers M.W. Vaccination for the prevention of cysticercosis. Developments in Biologicals 119 (2004) 361-368
129. Mafojane N.A., Appleton C.C., Krecek R.C., Michael L.M., and Willingham III A.L. The current status of neurocysticercosis in eastern and southern Africa. Acta Tropica 87 (2003) 25-33
130. Maguire J.H. Tapeworms and seizures - treatment and prevention. New England Journal of Medicine 350 (2004) 215-217
131. Manoutcharian K., Díaz-Orea A., Gevorkian G., Fragoso G., Acero G., González E., de Aluja A., Villalobos N., Gómez-Conde E., and Sciutto E. Recombinant bacteriophage-based multiepitope vaccine against Taenia solium pig cysticercosis. Veterinary Immunology and Immunopathology 99 (2004) 11-24
132. Margono S.S., Subahar R., Hamid A., Wandra T., Sudewi S.S., Sutisna P., and Ito A. Cysticercosis in Indonesia: epidemiological aspects. Southeast Asian Journal of Tropical Medicine and Public Health 32 (2001) 79-84
133. Martinez H.R., Rangel-Guerra R., Elizondo G., Gonzalez J., Todd L.E., Ancer J., and Prakash S. MR imaging in neurocysticercosis: a study of 56 cases. American Journal of Neuroradiology 10 (1989) 1011-1019
134. Mayta H., Talley A., Gilman R.H., Jiménez J., Verastegui M., Ruiz M., Garcia H.H., and Gonzalez A.E. Differentiating Taenia solium and Taenia saginata infections by simple hematoxylin-eosin staining and PCR-restriction enzyme analysis. Journal of Clinical Microbiology 38 (2000) 1333-1337
135. McCormick G.F. Cysticercosis - review of 230 patients. Bulletin of Clinical Neurosciences 50 (1985) 76-101
136. McManus, D.P. (2005). Molecular discrimination of taeniid cestodes. Parasitology International (in press; December 5, 2005 electronic publication).
137. McManus D.P., Garcia-Zepeda E., Reid A., Rishi A.K., and Flisser A. Human cysticercosis and taeniasis: molecular approaches for specific diagnosis and parasite identification. Acta Leiden 57 (1989) 81-91
138. McManus, D.P. and Ito, A. (2005). Application of molecular techniques for identification of the human Taenia, In: WHO/FAO/OIE Guidelines for the Surveillance, Prevention and Control of Taeniosis/Cysticercosis, (K.D. Murrell, ed.), pp. 52-55. Paris: Office International des Epizooties.
139. Morgan, B. and Hawkins, P. (1949). Veterinary Helminthology, p. 400. Minneapolis, MN: Burgess Publishing Company.
140. In: Murrell K.D. (Ed). WHO/FAO/OIE Guidelines for the Surveillance, Prevention and Control of Taeniosis/Cysticercosis (2005), Office International des Epizooties, Paris
141. Nakao M., Okamoto M., Sako Y., Yamasaki H., Nakaya K., and Ito A. A phylogenic hypothesis for the distribution of two genotypes of the pork tapeworm Taenia solium worldwide. Parasitology 124 (2002) 657-662
142. Nash T.E., Del Brutto O.H., Butman J.A., Corona T., Delgado-Escueta A., Duron R.M., Evans C.A., Gilman R.H., Gonzalez A.E., Loeb J.A., Medina M.T., Pietsch-Escueta S., Pretell E.J., Takayanagui O.M., Theodore W., Tsang V.C., and Garcia H.H. Calcific neurocysticercosis and epileptogenesis. Neurology 62 (2004) 1934-1938
143. Nash T.E., and Neva F.A. Recent advances in the diagnosis and treatment of cerebral cysticercosis. New England Journal of Medicine 311 (1984) 1492-1496
144. Nash T.E., and Patronas N.J. Edema associated with calcified lesions in neurocysticercosis. Neurology 53 (1999) 777-781
145. Nash T.E., Pretell J., and Garcia H.H. Calcified cysticerci provoke perilesional edema and seizures. Clinical Infectious Diseases 33 (2001) 1649-1653
146. Nguekam A., Zoli A.P., Vondou L., Pouedet S.M., Assana E., Dorny P., Brandt J., Losson B., and Geerts S. Kinetics of circulating antigens in pigs experimentally infected with Taenia solium eggs. Tropical Medicine and International Health 8 (2003) 144-149
147. Nguekam J.P., Zoli A.P., Zogo P.O., Kamga A.C.T., Speybroeck N., Dorny P., Brandt J., Losson B., and Geerts S. A seroepidemiological study of human cysticercosis in West Cameroon. Tropical Medicine and International Health 8 (2003) 144-149
148. Njoroge E., Mbithi P., Wachira T., Gathuma J., Gathura P., Maitho T.E., Magambo J., and Zeyhle E. Comparative study of albendazole and oxfendazole in the treatment of cystic echinococcosis in sheep and goats. International Journal of Applied Research in Veterinary Medicine 3 (2005) 97-1001
149. Nsengiyumva G., Druet-Cabanac M., Nzisabira L., Preux P.M., and Vergnenègre A. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study. Epilepsia 45 (2004) 673-677
150. Nunes C.M., Lima L.G., Manoel C.S., Pereira R.N., Nakano M.M., and Garcia J.F. Taenia saginata: polymerase chain reaction for taeniasis diagnosis in human fecal samples. Experimental Parasitology 104 (2003) 67-69
151. Okamoto M., Nakao M., Sako Y., and Ito A. Molecular variation of Taenia solium in the world. Southeast Asian Journal of Tropical Medicine and Public Health 32 supplement 2 (2001) 90-93
152. Okolo M.I. Cerebral cysticercosis in rural dogs. Microbios 47 (1986) 189-191
153. Okolo M.I. Observations on Cysticercus cellulosae in the flesh of rural dogs. International Journal of Zoonoses 13 (1986) 286-289
154. Pawlowski Z., Allan J., and Sarti E. Control of Taenia solium taeniasis/cysticercosis: from research towards implementation. International Journal of Parasitology 35 (2005) 1221-1232
155. Pawlowski Z., and Murrell K.D. Taeniasis and cysticercosis. In: Hui Y.H., Sattar S.A., Murrell K.D., Nip W.K., and Stanfield P.S. (Eds). Foodborne Disease Handbook (Second Edition), Volume 2: Viruses, Parasites, Pathogens and HAACP (2000), Marcel Dekker, Inc, New York 217-227
156. Pawlowski Z.S. Taenia solium: basic biology and transmission. In: Singh G., and Prabhakar S. (Eds). Taenia solium Cysticercosis. From Basic to Clinical Sciences (2002), CABI Publishing, Wallingford, United Kingdom 1-14
157. Peniche-Cardeña A., Dominguez-Alpizar J.L., Sima-Alvarez R., Argaez-Rodriguez F., Fraser A., Craig P.S., and Rodríguez-Canul R. Chemotherapy of porcine cysticercosis with albendazole sulphoxide. Veterinary Parasitology 108 (2002) 63-73
158. Phiri I.K., Dorny P., Gabriel S., Willingham III A.L., Speybroeck N., and Vercruysse J. The prevalence of porcine cysticercosis in Eastern and Southern provinces of Zambia. Veterinary Parasitology 108 (2002) 31-39
159. Phiri I.K., Ngowi H., Afonso S.M.S., Matenga E., Boa M., Mukaratirwa S., Githigia S.M., Saimo M.K., Sikasunge C.S., Maingi N., Lubega G.W., Kassuku A., Michael L.M., Siziya S., Krecek R.C., Noormahomed E., Vilhena M., Dorny P., and Willingham III A.L. The emergence of Taenia solium cysticercosis in Eastern and Southern Africa as a serious agricultural problem and public health risk. Acta Tropica 87 (2003) 13-23
160. Pouedet M.S.R., Zoli A.P., Nguekam L., Vondou L., Assana E., Speybroeck N., Berkvens D., Dorny P., Brandt J., and Geerts S. Epidemiological survey of swine cysticercosis in two rural communities of West-Cameroon. Veterinary Parasitology 106 (2002) 45-54
161. Pretell E.J., Garcia H.H., Gilman R.H., Saavedra H., and Martinez M. Failure of one-day praziquantel treatment in patients with multiple neurocysticercosis lesions. Clinical Neurology and Neurosurgery 103 (2001) 175-177
162. Preux P.M., and Druet-Cabanac M. Epidemiology and aetiology of epilepsy in sub-Saharan Africa. Lancet Neurology 4 (2005) 21-31
163. Preux P.M., Thiemagni F., Fodzo L., Kandem P., Ngouafong P., Ndongo F., Macharia W., Dongmo L., and Dumas M. Antiepileptic therapies in the Mifi Province in Cameroon. Epilepsia 41 (2000) 432-439
164. Proaño J.V., Madrazo I., Avelar F., Lopez-Felix B., Diaz G., and Grijalva I. Medical treatment for neurocysticercosis characterized by giant subarachnoid cysts. New England Journal of Medicine 345 (2001) 879-885
165. Rajshekhar V., Joshi D.D., Doanh N.Q., De N.V., and Zhou X.N. Taenia solium taeniosis/cysticercosis in Asia: epidemiology, impact and issues. Acta Tropica 87 (2003) 53-60
166. Richards F.O., Schantz P.M., Ruiz-Tiben E., and Sorvillo F.J. Cysticercosis in Los Angeles County. Journal of the American Medical Association 254 (1985) 3444-3448
167. Rickard M.D., and Williams J.F. Hydatidosis/cysticercosis: immune mechanisms and immunization against infection. Advances in Parasitology 21 (1982) 229-296
168. Riley T., and White Jr. A.C. Management of neurocysticercosis. CNS Drugs 17 (2003) 577-591
169. Roberts T., Murrell K.D., and Marks S. Economic losses caused by food-borne parasitic diseases. Parasitology Today 10 (1994) 419-423
170. Rodriguez-Canul R., Argaez-Rodriguez F., Pacheco de la Gala D., Villegas-Perez S., Fraser A., Craig P.S., Cob-Galera L., and Domínguez-Alpizar J.L. Taenia solium metacestode viability in infected pork after preparation with salt pickling or cooking methods common in Yucatán, México. Journal of Food Protection 65 (2002) 666-669
171. Rodriguez-Canul R., Fraser A., Allan J.C., Dominguez-Alpizar J.L., Argaez-Rodriguez F., and Craig P.S. Epidemiological study of Taenia solium taeniasis/cysticercosis in a rural village in Yucatan state, Mexico. Annals of Tropical Medicine and Parasitology 93 (1999) 57-67
172. Rodriguez-Hidalgo R., Geysen D., Benitez-Ortiz W., Geerts S., and Brandt J. Comparison of conventional techniques to differentiate between Taenia solium and Taenia saginata and an improved polymerase chain reaction-restriction fragment length polymorphism assay using a mitochondrial 12S rDNA fragment. Journal of Parasitology 88 (2002) 1007-1011
173. Román G., Sotelo J., Del Brutto O., Flisser A., Dumas M., Wadia N., Botero D., Cruz M., Garcia H., de Bittencourt P.R.M., Trelles L., Arriagada C., Lorenzana P., Nash T.E., and Spina-França A. A proposal to declare neurocysticercosis an international reportable disease. Bulletin of the World Health Organization 78 (2000) 399-406
174. Rosenfeld E.A., Byrd S.E., and Shulman S.T. Neurocysticercosis among children in Chicago. Clinical Infectious Diseases 23 (1996) 262-268
175. Sahai K., Kapila K., and Verma K. Parasites in fine needle breast aspirates-assessment of host tissue response. Postgraduate Medical Journal 78 (2002) 165-167
176. Sakai H., Sone M., Castro D.M., Nonaka N., Quan D., Canales M., Ljungstrom I., and Sanchez A.L. Seroprevalence of Taenia solium cysticercosis in pigs in a rural community of Honduras. Veterinary Parasitology 78 (1998) 233-238
177. Sako Y., Nako M., Ikejima T., Piao X.Z., Nakaya K., and Ito A. Molecular characterization and diagnostic value of Taenia solium low-molecular weight antigen genes. Journal of Clinical Microbiology 38 (2000) 4439-4444
178. Sanchez A.L., Gomez O., Allebeck P., Cosenza H., and Ljungstrom L. Epidemiological study of Taenia solium infections in a rural village in Honduras. Annals of Tropical Medicine and Parasitology 91 (1997) 163-171
179. Sanchez A.L., Medina M.T., and Ljungstrom I. Prevalence of taeniasis and cysticercosis in a population of urban residence in Honduras. Acta Tropica 69 (1998) 141-149
180. Sarti E., Flisser A., Schantz P.M., Gleizer M., Loya M., Plancarte A., Avila G., Allan J., Craig P., Bronfman M., and Wijeyaratne P. Development and evaluation of a health education intervention against Taenia solium in a rural community in Mexico. American Journal of Tropical Medicine and Hygiene 56 (1997) 127-132
181. Sarti E., Schantz P.M., Avila G., Ambrosio J., Medina-Santillan R., and Flisser A. Mass treatment against human taeniasis for the control of cysticercosis: a population-based intervention study. Transactions of the Royal Society of Tropical Medicine and Hygiene 94 (2000) 85-89
182. Sarti E., Schantz P.M., Plancarte A., Wilson M., Gutierrez I.O., and Lopez A.S. Prevalence and risk factors for Taenia solium taeniasis and cysticercosis in humans and pigs in a village in Morelos, Mexico. American Journal of Tropical Medicine and Hygiene 46 (1992) 677-685
183. Sarti E., Schantz P.M., Plancarte A., Wilson M., Gutierrez O.I., Aguilera J., Roberts J., and Flisser A. Epidemiological investigation of Taenia solium taeniasis and cysticercosis in a rural village of Michoacan state, Mexico. Transactions of the Royal Society for Tropical Medicine and Hygiene 88 (1994) 49-52
184. Sato M.O., Yamasaki H., Sako Y., Nakao M., Nakaya K., Plancarte A., Kassuku A.A., Dorny P., Geerts S., Benitez-Ortiz W., Hashiguchi Y., and Ito A. Evaluation of tongue inspection and serology for diagnosis of Taenia solium cysticercosis in swine: usefulness of ELISA using purified glycoproteins and recombinant antigen. Veterinary Parasitology 111 (2003) 309-322
185. Schantz P.M., Cruz M., Sarti E., and Pawlowski Z. Potential eradicability of taeniasis and cysticercosis. Bulletin of the Pan American Health Organization 27 (1993) 397-403
186. Schantz P.M., Moore A.C., Munoz J.L., Hartman B.J., Schaefer J.A., Aron A.M., Persaud D., Sarti E., Wilson M., and Flisser A. Neurocysticercosis in an orthodox Jewish community in New York City. New England Journal Medicine 327 (1992) 692-695
187. Schantz P.M., and Sarti-Guttierez E. Diagnostic methods and epidemiologic surveillance of Taenia solium infection. Acta Leidensia 57 (1989) 153-164
188. Schantz P.M., Wilkins P.P., and Tsang V.C.W. Immigrants, imaging and immunoblots: the emergence of neurocysticercosis as a significant public health problem. In: Scheld W.M., Craig W.A., and Hughes J.M. (Eds). Emerging Infections 2 (1998), ASM Press, Washington 213-241
189. Scheel C.M., Khan A., Hancock K., Garcia H.H., Gonzalez A.E., Gilman R.H., Tsang V.C.W., and the Cysticercosis Working Group in Peru. Serodiagnosis of neurocysticercosis using synthetic 8-kd proteins: comparison of assay formats. American Journal of Tropical Medicine and Hygiene 73 (2005) 771-776
190. Sciutto E., Fragoso G., Manoutcharian K., Gevorkian G., Rosas-Salgado G., Hernández-Gonzalez M., Herrera-Estrella L., Cabrera-Ponce J.L., López-Casillas F., González-Bonilla C., Santiago-Machuca A., Ruíz-Pérez F., Sánchez J., Goldbaum F., Aluja A., and Larralde C. New approaches to improve a peptide vaccine against porcine Taenia solium cysticercosis. Archives of Medical Research 33 (2002) 371-378
191. Sciutto E., Martinez J.J., Villalobos N.M., Hernandez M., Jose M.V., Beltran C., Rodarte F., Flores I., Bobadilla J.R., Fragoso G., Parkhouse M.E., Harrison L.J., and de Aluja A.S. Limitations of current diagnostic procedures for the diagnosis of Taenia solium cysticercosis in rural pigs. Veterinary Parasitology 79 (1998) 299-313
192. Shasha W., and Pammenter M.D. Sero-epidemiological studies of cysticercosis in school children from two rural areas of Transkei, South Africa. Annals of Tropical Medicine and Parasitology 85 (1991) 349-355
193. Shey-Njila O., Zoli P.A., Awah-Ndukum J., Nguekam J.P., Assana E., Byambas P., Dorny P., Brandt J., and Geerts S. Porcine cysticercosis in village pigs of northwest Cameroon. Journal of Helminthology 77 (2003) 351-354
194. Singh G., and Prabhakar S. Taenia solium Cysticercosis. From Basic to Clinical Science (2002), CABI Publishing, Wallingford, United Kingdom
195. Sorvillo F.J., Portigal L., DeGiorgio C., Smith L., Waterman S.H., Berlin G.W., and Ash L.R. Cysticercosis mortality in California. Emerging Infectious Diseases 10 (2004) 465-469
196. Sorvillo F.J., Waterman S.H., Richards F.O., and Schantz P.M. Cysticercosis surveillance: locally acquired and travel-related infections and detection of intestinal tapeworm carriers in Los Angeles County. American Journal of Tropical Medicine and Hygiene 47 (1992) 365-371
197. Sotelo J., del Brutto O.H., Penagos P., Escobedo F., Torres B., and Rodriguez-Carbajal J. Comparison of therapeutic regimen of anticysticercal drugs for parenchymal brain cysticercosis. Neurology 237 (1990) 69-72
198. Sotelo J., Escobedo F., and Penagos P. Albendazole vs praziquantel for therapy for neurocysticercosis: a controlled trial. Archives of Neurology 45 (1988) 532-534
199. Sotelo J., Escobedo F., Rodriguez-Carbajal J., Torres B., and Rubio-Donnadieu F. Therapy of parenchymal brain cysticercosis with praziquantel. New England Journal of Medicine 310 (1984) 1001-1007
200. Sotelo J., Rosas N., and Palencia G. Freezing of infested pork muscle kills cysticerci. Journal of American Medical Association 256 (1986) 893-894
201. Statistics South Africa (2004). Mid-year population estimates, South Africa 2004. Statistical Release P0302.
202. Subahar R., Hamid A., Purba W., Sandra T., Karma C., Sako Y., Margono S.S., Craig P.S., and Ito A. Taenia solium infection in Irian Jaya (west Papua), Indonesia: a pilot serological survey of human and porcine cysticercosis in Jayawijaya District. Transactions of the Royal Society of Tropical Medicine and Hygiene 95 (2001) 388-390
203. The Medical Letter, Inc. (2004). Drugs for parasitic infections. In: The Medical Letter on Drugs and Therapeutics, August 2004 (M. Abramowicz, ed.), p. 12. New York: The Medical Letter, Inc., www.medicalletter.org.
204. Thomas S.V., Sarma P.S., Alexander M., Pandit L., Shekhar L., Trivedi C., and Vengamma B. Economic burden of epilepsy in India. Epilepsia 42 (2001) 1052-1060
205. Thomson A.J.G. Neurocysticercosis - experience at the teaching hospitals of the University of Cape Town. South African Medical Journal 83 (1993) 332-334
206. Torres A., Plancarte A., Villalobos A.N., de Aluja A.S., Navarro R., and Flisser A. Praziquantel treatment of porcine brain and muscle Taenia solium cysticercosis. 3. Effect of 1-day treatment. Parasitology Research 78 (1992) 161-164
207. Torres J.R., Noya O., Noya B.A., and Mondolfi A.G. Seizures and praziquantel. A case report. Revista do Instituto de Medicina Tropical de Sao Paulo 30 (1988) 433
208. Townes J.M., Hoffmann C.J., and Kohn M.A. Neurocysticercosis in Oregon, 1995-2000. Emerging Infectious Diseases 10 (2004) 508-510
209. Tsang V.C., Brand J.A., and Boyer A.E. An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). Journal of Infectious Diseases 159 (1989) 50-59
210. Tsang V.C., Pilcher J.A., Zhou W., Boyer A.E., Kamango-Sollo E.I., Rhoads M.L., Murrell K.D., Schantz P.M., and Gilman R.H. Efficacy of the immunoblot assay for cysticercosis in pigs and modulated expression of distinct IgM/IgG activities to Taenia solium antigens in experimental infections. Veterinary Immunology and Immunopathology 29 (1991) 69-78
211. van Hout B., Gagnon D., Souetre E., Ried S., Remy C., Baker G., Genton P., Vespignani H., and McNulty P. Relationship between seizure frequency and costs and quality of life of outpatients with partial epilepsy in France, Germany, and the United Kingdom. Epilepsia 38 (1997) 1221-1226
212. Vazquez-Flores S., Ballesteros-Rodea G., Flisser A., and Schantz P.M. Hygiene and restraint of pigs is associated with absence of Taenia solium cysticercosis in a rural community of Mexico. Salud Pública de México 43 (2001) 574-576
213. Vazquez M.L., Jung H., and Sotelo J. Plasma levels of praziquantel decrease when dexamethasone is given simultaneously. Neurology 37 (1987) 1561-1562
214. Velasco-Suarez M., Bravo M.A., and Quirasco F. Human cysticercosis medical-social implications and economic impact. In: Flisser A., Willms K., Laclette J.P., Larralde C., Ridaura C., and Beltran F. (Eds). Cysticercosis: Present State of Knowledge and Perspectives (1982), Academic Press, New York 47-51
215. Wandra T., Ito A., Yamasaki H., Seroso T., and Margono S.S. Taenia solium cysticercosis, Irian Jaya, Indonesia. Emerging Infectious Diseases 9 (2003) 884-885
216. White Jr. A.C. Neurocysticercosis: updates on epidemiology, pathogenesis, diagnosis and management. Annual Review of Medicine 51 (2000) 187-206
217. White A.C., and Garcia H.H. Recent developments in the epidemiology, diagnosis, treatment, and prevention of neurocysticercosis. Current Infectious Diseases Report 1 (1999) 434-440
218. White Jr. A.C., Robinson P., and Kuhn R. Taenia solium cysticercosis: host-parasite interactions and the immune response. Chemical Immunology 66 (1997) 209-230
219. Wilkins P.P., Allan J.C., Verastegui M., Acosta M., Eason A.G., Garcia H.H., Gonzalez A.E., Gilman R.H., and Tsang V.C. Development of a serologic assay to detect Taenia solium taeniasis. American Journal of Tropical Medicine and Hygiene 60 (1999) 199-204
220. Wilkins P.P., Wilson M., Allan J.C., and Tsang V.C.W. Taenia solium cysticercosis: immunodiagnosis of neurocysticercosis and taeniasis. In: Singh G., and Prabhakar S. (Eds). Taenia solium Cysticercosis: From Basic to Clinical Science (2002), CABI Publishing, Wallingford, United Kingdom 329-341
221. Willingham III A.L., De N.V., Doanh N.Q., Cong L.D., Dung T.V., Dorny P., Cam P.D., and Dalsgaard A. Current status of cysticercosis in Vietnam. Southeast Asian Journal of Tropical Medicine and Public Health 34 supplement (2003) 35-50
222. Wilson M., Bryan R.T., Fried J.A., Ware D.A., Shantz P.M., Pilcher J.B., and Tsang V.C. Clinical evaluation of the cysticercosis enzyme-linked immunoelectrotransfer blot in patients with neurocysticercosis. Journal of Infectious Diseases 164 (1991) 1007-1009
223. World Health Organization (WHO). Bringing Epilepsy Out of the Shadows in Africa (Press Release, WHO 30, 4 May 2000) (2000), World Health Organization, Geneva
224. World Health Organization (WHO). Epilepsy: An Historical Overview. WHO Fact Sheet 168 (2001), World Health Organization, Geneva
225. World Health Organization (WHO) (2003). Control of neurocysticercosis. Report of the Secretariat, Fifty-sixth World Health Assembly. Document A56/10. Geneva: World Health Organization.
226. Yamasaki H., Allan J.C., Sato M.O., Nakao M., Sako Y., Nakaya K., Qiu D., Mamuti W., Craig P.S., and Ito A. DNA differential diagnosis of taeniasis/cysticercosis by multiplex PCR. Journal of Clinical Microbiology 42 (2004) 548-553
227. Yamasaki H., Nakao M., Sako Y., Nakaya K., Sato M.O., Mamuti W., Okamoto M., and Ito A. DNA differential diagnosis of human taeniid cestodes by base excision sequence scanning thymine-base reader analysis with mitochondrial genes. Journal of Clinical Microbiology 40 (2002) 3818-3821
228. Yancey L.S., Diaz-Marchan P.J., and White A.C. Cysticercosis: recent advances in diagnosis and management of neurocysticercosis. Current Infectious Disease Reports 7 (2005) 39-47
229. Zini D., Farrell V.J.R., and Wadee A.A. The relationship of antibody levels to the clinical spectrum of human neurocysticercosis. Journal of Neurology, Neurosurgery and Psychiatry 53 (1990) 656-661
230. Zoli A., Shey-Njila O., Assana E., Nguekam J.P., Dorny P., Brandt J., and Geerts S. Regional status, epidemiology and impact of Taenia solium cysticercosis in Western and Central Africa. Acta Tropica 87 (2003) 35-42
231. Zoli P.A., and Tchoumboué J. Prevalence de la cysticercose porcine dans le Departement de la Menoua (Ouest-Cameroun). Cameroon Bulletin of Animal Production 1 (1992) 42-47